Acceleron  

Publications

Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low- Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE‐MDS Study; 21st Congress of the European Hematology Association; June 9-12, 2016

View presentation here